clenbuterol has been researched along with Obesity in 9 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 7.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 7.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| " The different dosing and mode of administration will lower the risk of side effects, increase the safety profile, and could facilitate use in the anti-obesity market." | 5.62 | Oxidized Hyaluronic Acid Hydrogels as a Carrier for Constant-Release Clenbuterol Against High-Fat Diet-Induced Obesity in Mice. ( Chen, WY; Lin, FH, 2021) |
| "C57Bl/6N mice with diet-induced obesity were treated both acutely and for up to 42 days with a wide range of clenbuterol dosages and treatment durations." | 3.96 | Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity. ( Åslund, A; Bengtsson, T; Berlin, R; Dehvari, N; Forsberg, E; Halleskog, C; Hoeks, J; Kalinovich, A; Olsen, J; Östenson, CG; Rinde, M; Sandström, A; Schaart, G; van Beek, S; Zacharewicz, E, 2020) |
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 3.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| "The effects of aerobic exercise training, chronic administration of the selective beta 2-adrenergic agonist clenbuterol, and the combination of these two treatments on muscle insulin resistance were compared in female obese (fa/fa) Zucker rats." | 3.68 | Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle. ( Brozinick, JT; Etgen, GJ; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 3.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Meister, J | 1 |
| Bone, DBJ | 1 |
| Knudsen, JR | 1 |
| Barella, LF | 1 |
| Liu, L | 1 |
| Lee, R | 1 |
| Gavrilova, O | 1 |
| Chen, M | 1 |
| Weinstein, LS | 1 |
| Kleinert, M | 1 |
| Jensen, TE | 1 |
| Wess, J | 1 |
| Kalinovich, A | 1 |
| Dehvari, N | 1 |
| Åslund, A | 1 |
| van Beek, S | 1 |
| Halleskog, C | 1 |
| Olsen, J | 1 |
| Forsberg, E | 1 |
| Zacharewicz, E | 1 |
| Schaart, G | 1 |
| Rinde, M | 1 |
| Sandström, A | 1 |
| Berlin, R | 1 |
| Östenson, CG | 1 |
| Hoeks, J | 1 |
| Bengtsson, T | 1 |
| Chen, WY | 1 |
| Lin, FH | 1 |
| Torgan, CE | 2 |
| Etgen, GJ | 1 |
| Brozinick, JT | 2 |
| Wilcox, RE | 2 |
| Ivy, JL | 5 |
| Banks, EA | 1 |
| Cortez, MY | 1 |
| Kuo, CH | 1 |
| Ding, Z | 2 |
| Goalstone, ML | 1 |
| Wall, K | 1 |
| Leitner, JW | 1 |
| Kurowski, T | 1 |
| Ruderman, N | 1 |
| Pan, SJ | 2 |
| Moller, DE | 1 |
| Draznin, B | 1 |
| Hancock, J | 1 |
| Fogt, D | 1 |
| Lee, M | 1 |
| Rothwell, NJ | 1 |
| Stock, MJ | 1 |
9 other studies available for clenbuterol and Obesity
| Article | Year |
|---|---|
In vivo metabolic effects after acute activation of skeletal muscle G
Topics: Animals; Clenbuterol; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; GTP-Binding P | 2022 |
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Clenbuterol; Fatty Liver; Glucose; Homeostasis; Insuli | 2020 |
Oxidized Hyaluronic Acid Hydrogels as a Carrier for Constant-Release Clenbuterol Against High-Fat Diet-Induced Obesity in Mice.
Topics: 3T3-L1 Cells; Adipogenesis; Administration, Oral; Animals; Clenbuterol; Delayed-Action Preparations; | 2021 |
Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle.
Topics: Aerobiosis; Animals; Body Weight; Citrate (si)-Synthase; Clenbuterol; Enzymes; Female; Glucose; Hind | 1993 |
Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats.
Topics: 3-O-Methylglucose; Animals; Biological Transport; Body Weight; Citrate (si)-Synthase; Clenbuterol; D | 1993 |
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C | 1996 |
Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Aurothioglucose; Blood Glucose; Body Weight; Clenbu | 1999 |
Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Clenbuterol; Female; Glucose; Glycoge | 2001 |
Influence of clenbuterol on energy balance, thermogenesis and body composition in lean and genetically obese Zucker rats.
Topics: Adipose Tissue, Brown; Animals; Body Composition; Body Temperature Regulation; Body Weight; Clenbute | 1987 |